Full name
VYAIRE MEDICAL PRODUCTS LIMITED (SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ) ODDZIAŁ W POLSCE
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
70.22.Z - Business and other management consultancy activities
73.1 - Advertising
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -113 | -112 | -36,3 | 67,6 |
Gross profit (loss) | -125,6 | -98,9 | -122,5 | -23,9 |
EBITDA | -113 | -89,7 | -33,8 | 62,3 |
Short time liabilities | 88,4 | 250,8 | 445,8 | 77,7 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | -310,4 | -409,3 | -531,8 | -29,9 |
Operating profit (EBIT) | -113 | -89,7 | -33,8 | 62,3 |
Assets | 27,5 | 57 | 91,8 | 61,1 |
Net profit (loss) | -134,6 | -98,9 | -122,5 | -23,9 |
Cash | 6,5 | 2,8 | 29,2 | 931,4 |
Net income from sale | 407,2 | 425,4 | 215,1 | -49,4 |
Liabilities and provisions for liabilities | 337,9 | 466,3 | 623,5 | 33,7 |
Working assets | 27,5 | 57 | 91,8 | 61,1 |
Other income costs | 0 | 22,2 | 2,4 | -89 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 43,4 | 24,2 | 23 | -1,2 |
Equity capital to total assets | -1129,3 | -718,4 | -579,3 | 139,1 |
Gross profit margin | -30,8 | -23,2 | -56,9 | -33,7 |
EBITDA Margin | -27,8 | -21,1 | -15,7 | 5,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 79 | 215 | 756 | 541 |
Current financial liquidity indicator | 0.31102433800697327 | 0.22717337310314178 | 0.205912247300148 | 0 |
Net dept to EBITDA | 0.057554326951503754 | 0.031574785709381104 | 0.8635757565498352 | 0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane